Hematology Diagnostics Market Report
Hematology Diagnostics Market, By Product (Hematology Instruments, Hematology Consumables), Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit), End-Use (Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others), and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Hematology Diagnostics market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Hematology Diagnostics Market, By Product (Hematology Instruments, Hematology Consumables), Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit), End-Use (Diagnostic Laboratories, Hospitals & Clinics, Academic Institutes, Others), and Region - ...
Impact of COVID-19 on Hematology Diagnostics Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Hematology Diagnostics Market is projected to grow from USD 5.9 billion in 2020 to USD 8.3 billion by 2026 at a CAGR of around 5.8% during the forecast period.
Hematology is defined as the study of blood, blood diseases, and blood-forming organs. Hematology treatment is used to treat certain bleeding disorders such as hemophilia and blood clots, and blood cancer. Based on product, hematology diagnostics can be categorized as hematology instruments and hematology consumables.
Key players operating in the Hematology Diagnostics market are-
The growth of the hematology diagnostics market is primarily driven by rising incidences of blood disorders. Expanding geriatric population is likely to drive the market growth further. Rising awareness among consumers relating to blood disorders is expected to augment the market growth substantially. In addition to this, increasing investment in research and development activities to develop advanced diagnostic solutions is likely to create lucrative opportunities for the players operating in the global hematology diagnostics market in the coming years.
By end-use, the hematology diagnostics market has been bifurcated into diagnostic laboratories, hospitals & clinics, academic institutes, and others. The hospitals & clinics segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment can be attributed to the presence of established infrastructure and skilled staff.
By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to expanding geriatric populace and growing emphasis on the adoption of advanced diagnostic solutions in the healthcare industry coupled with the presence of key market players such as Abbott Laboratories (US) and Beckman Coulter Inc. (US). The market growth in Asia-Pacific is expected to be driven by an increasing number of people having blood disorders.
The covid-19 outbreak posed significant challenges across verticals worldwide. It impacted the growth of the hematology diagnostics market negatively as the diagnostic procedures declined due to fear of coronavirus infection. Also, supply chain disruptions due to the imposition of lockdown affected the product availability on time and thus, affected the market growth.
Here is the list of the group of customers that the hematology diagnostics market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at email@example.com.
The hematology diagnostics market is expected to witness an impressive growth of 5.8% CAGR in the coming years.
Abbott Laboratories (US), Sysmex Corporation (Japan), F. Hoffmann-La Roche AG (Switzerland), Beckman Coulter Inc. (US), Horiba, Ltd. (Japan), Bio-Rad Laboratories, Inc. (US), Siemens Healthineers AG (Germany), Mindray Medical International Limited (China), Nihon Kohden Cor-poration (Japan) and EKF Diagnostics (Germany) are among the key players in the hematology diagnostics market.
The hematology diagnostics market size is expected to reach USD 8.3 billion in the foreseeable future.
The hospitals & clinics segment is expected to register significant growth in the hematology diagnostics market in the coming years.
North America accounted for the largest share in the hematology diagnostics market in 2020.
Hematology diagnostics distributors, Hematology diagnostics suppliers, Hematology diagnostics manufacturers, Logistics organizations, Government bodies are the target audience in the hematology diagnostics market.